However, the number of reported individuals with heterozygous CASQ2-, KCNJ2-, CALM1-, CALM2- or CALM3-related CPVT is quite limited which precludes a robust estimation of penetrance at this time [10]. The gene discussed is CALM3; the disease is catecholaminergic polymorphic ventricular tachycardia.